Skip to content
thestock.space

As of 6 Nov 2026, Sharma East India Hospitals & Medical Research trades at 23.5× trailing earnings, below the industry P/E of 47.7×, and the shares are 44% below their 52-week high. It earns ROCE of 14% and ROE of 9.5%, and sales and net profit grew 20% and 14% a year over 3 years. Debt is 0.53× equity. It is a small-cap company with a market cap of ₹28 Cr, ranked 33rd of 40 Medical Care Facilities companies by market cap; the shares fell 45% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹78.01
Day high
₹85.00
Day low
₹74.00
Prev. close
₹78.00
Volume
553

Health check

1 good · 3 fair · 2 to check
  • ReturnsBehind

    −44.7% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 23.5 vs industry 47.7.

  • GrowthSteady

    Sales +20.1%, profit +14.2% a year over 3 years.

  • ProfitabilityAverage

    ROCE 13.8% vs peer median 11.9%.

  • Balance sheetFair

    Debt 0.53× equity, interest covered 4.5×, Piotroski 5 of 9.

  • Red flags2 to check

    Quarterly profit down 18.2% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹28 Cr, #33 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹37 Cr · profit ₹1 Cr
Market cap
₹28 Cr
Small cap
P/E
23.5
Industry 47.7
Price to book
2.03
Peers 8.06
Dividend yield
0.00%
ROE
9.5%
Peers 12.8%
ROCE
13.8%
Peers 11.9%
Debt to equity
0.53
Debt ₹7.29 Cr
EPS (TTM)
₹3.61
OPM (TTM)
9.6%
Net margin 3.2%
Sales growth
+13.6%
Latest quarter vs a year ago
Profit growth
−18.2%
Latest quarter vs a year ago
Price to sales
0.75
EV/EBITDA 9.6

Strengths and risks

Strengths

  • P/E of 23.5 against an industry P/E of 47.7.

Risks to check

  • Quarterly profit down 18.2% on a year ago.
  • 44% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Sharma East India Hospitals & Medical Research

Sharma East India Hospitals & Medical Research Ltd, a multi-specialty hospital, provides medical and healthcare services. It offers various services, such as obstetrics and gynaecology for women's health, general and laparoscopic surgery, general medicine, orthopedic surgery with joint replacement, cardiology and CTVS for heart and vascular care, plastic and reconstructive surgery, pathology, ENT, ophthalmology, neurology, pediatrics, and ICU and…

Headquarters
Jaipur
Employees
234
Sector
Healthcare
ISIN
INE465H01012
Website
jaipurhospital.co.in

Price range

52 weeks

₹74.00₹150.50

Today

₹74.00₹85.00
Avg volume (3M)
240
1-year return
minus 44.7%
From 52-week high
minus 43.6%

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
SHARMEHSharma East India Hospitals & Medical Research84.89plus 8.83%2823.52.0313.8%9.5%9.6%20.1%14.2%0.00%minus 44.7%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
9.59.49.67.510.8
8.58.48.86.59.9
0.90.90.810.9
9.8%10.0%8.0%13.5%8.0%
00.1000
0.10.10.10.20.2
0.40.40.40.40.4
0.40.50.20.40.4
26.0%30.3%28.5%0.1%26.0%
0.30.30.20.40.3
0.970.970.541.310.79

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+20.1%
Profit CAGR 3Y
+14.2%
EPS CAGR 3Y
+8.5%
ROE
9.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
20.718.529.935.9
–minus 10.6%+61.3%+20.3%
17.420.426.232.3
3.3−1.93.73.6
15.9%−10.1%12.2%10.1%
0−00.10.1
1.10.80.60.4
1.41.51.81.7
–5.20.2–
0.811.41.6
−5.2%33.9%11.9%20.6%
0.80.71.21.2
–minus 20.5%+87.7%minus 0.1%
2.962.023.793.78

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4.24.24.24.2
6.47.18.39.6
8.352.37.3
4.88.912.911.9
23.725.227.732.9
9.17.79.48.4
2.310.23.43.7
0.70.50.40.5
11.76.814.520.3
23.725.227.732.9

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1.3−1.16.7−3.9
−3.65.2−3.3−0.6
2.8−4.2−3.54.5
0.4−0.2−0.10
−3.6−1.5−3.8−0.8
−2.4−2.72.9−4.7

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you